Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis
- PMID: 35682448
- PMCID: PMC9180091
- DOI: 10.3390/ijerph19116865
Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis
Abstract
We aimed to review the data available to evaluate the long-term consequences of coronavirus disease 2019 (COVID-19) at 6 months and above. We searched relevant observational cohort studies up to 9 February 2022 in Pubmed, Embase, and Web of Science. Random-effects inverse-variance models were used to evaluate the Pooled Prevalence (PP) and its 95% confidence interval (CI) of long-term consequences. The Newcastle−Ottawa quality assessment scale was used to assess the quality of the included cohort studies. A total of 40 studies involving 10,945 cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection were included. Of the patients, 63.87% had at least one consequence at the 6 month follow-up, which decreased to 58.89% at 12 months. The most common symptoms were fatigue or muscle weakness (PP 6−12 m = 54.21%, PP ≥ 12 m = 34.22%) and mild dyspnea (Modified Medical Research Council Dyspnea Scale, mMRC = 0, PP 6−12 m = 74.60%, PP ≥ 12 m = 80.64%). Abnormal computerized tomography (CT; PP 6−12 m = 55.68%, PP ≥ 12 m = 43.76%) and lung diffuse function impairment, i.e., a carbon monoxide diffusing capacity (DLCO) of < 80% were common (PP 6−12 m = 49.10%, PP ≥ 12 m = 31.80%). Anxiety and depression (PP 6−12 m = 33.49%, PP ≥ 12 m = 35.40%) and pain or discomfort (PP 6−12 m = 33.26%, PP ≥ 12 m = 35.31%) were the most common problems that affected patients’ quality of life. Our findings suggest a significant long-term impact on health and quality of life due to COVID-19, and as waves of ASRS-CoV-2 infections emerge, the long-term effects of COVID-19 will not only increase the difficulty of care for COVID-19 survivors and the setting of public health policy but also might lead to another public health crisis following the current pandemic, which would also increase the global long-term burden of disease.
Keywords: COVID-19; long-term consequence; meta-analysis; systematic review.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization . WHO Coronavirus (COVID-19) Dashboard. World Health Organization; Geneva, Switzerland: 2022.
-
- World Health Organization . WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—30 October 2020. World Health Organization; Geneva, Switzerland: 2020. [(accessed on 6 April 2022)]. Available online: https://www.who.int/director-general/speeches/detail/who-director-genera....
-
- World Health Organization . A Clinical Case Definition of Post COVID-19 Condition by a Delphi Consensus. World Health Organization; Geneva, Switzerland: 2021. [(accessed on 6 April 2022)]. Available online: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond....
-
- The Royal Society Long COVID: What Is It, and What Is Needed? 2020. [(accessed on 6 April 2022)]. Available online: https://royalsociety.org/-/media/policy/projects/set-c/set-c-long-covid.pdf.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
